https://www.hcplive.com/view/systemic-ocular-risk-factors-predict-treatment-aflibercept-dme
Factors including a longer diabetes duration and lower eGFR were associated with suboptimal treatment response to aflibercept in patients with DME.
Create an account
or login to join the discussion